Acute zonal occult outer retinopathy
| Acute zonal occult outer retinopathy | |
|---|---|
| Synonyms | AZOOR |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Sudden onset of visual field loss, photopsia |
| Complications | Vision loss |
| Onset | Sudden |
| Duration | Variable |
| Types | N/A |
| Causes | Unknown |
| Risks | Possible association with autoimmune disease |
| Diagnosis | Visual field test, Electroretinography |
| Differential diagnosis | Retinitis pigmentosa, Multiple evanescent white dot syndrome |
| Prevention | N/A |
| Treatment | No established treatment, corticosteroids sometimes used |
| Medication | N/A |
| Prognosis | Variable, some cases stabilize, others progress |
| Frequency | Rare |
| Deaths | N/A |
A rare retinal disease affecting vision
Acute zonal occult outer retinopathy (AZOOR) is a rare retinal disorder characterized by sudden onset of visual field loss, often accompanied by photopsia, or the perception of flashing lights. The condition primarily affects young to middle-aged adults and is more prevalent in females. AZOOR is part of a group of retinal diseases known as the "AZOOR complex," which also includes acute macular neuroretinopathy, acute idiopathic blind spot enlargement, and multifocal choroiditis.
Pathophysiology
The exact cause of AZOOR is not well understood, but it is believed to involve an inflammatory process affecting the outer retina, particularly the photoreceptor layer. The disease may be associated with viral infections or autoimmune responses, although no specific pathogen has been consistently identified. The condition is characterized by the loss of photoreceptors in one or more zones of the retina, leading to the characteristic visual field defects.
Clinical Presentation
Patients with AZOOR typically present with sudden onset of visual disturbances, which may include:
- Loss of visual field in one or both eyes
- Photopsia (flashing lights)
- Decreased visual acuity
- Metamorphopsia (distorted vision)
The visual field loss is often described as a "zonal" defect, affecting specific areas of the visual field while sparing others. The condition can be unilateral or bilateral, and the severity of symptoms can vary widely among patients.
Diagnosis
The diagnosis of AZOOR is primarily clinical, based on the patient's symptoms and the characteristic appearance of the retina on examination. Diagnostic tests that may be used to support the diagnosis include:
- Visual field tests to map the extent of visual field loss
- Optical coherence tomography (OCT) to assess the integrity of the retinal layers
- Electroretinography (ERG) to evaluate retinal function, often showing reduced or absent responses in affected areas
- Fluorescein angiography to rule out other retinal vascular conditions
Management
There is no specific treatment for AZOOR, and management is primarily supportive. Some patients may experience spontaneous improvement in their symptoms, while others may have persistent visual field defects. Treatment options that have been explored include:
- Corticosteroids to reduce inflammation
- Immunosuppressive therapy in cases suspected to have an autoimmune component
- Antiviral medications if a viral etiology is suspected
Prognosis
The prognosis for patients with AZOOR varies. Some individuals may experience partial or complete recovery of vision, while others may have permanent visual field defects. The condition can be stable or progressive, and long-term follow-up is often necessary to monitor changes in vision.
Related pages
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD